Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.

Pharmaceutical

Esperion Therapeutics

Sheldon Koenig

Ray Mastriani

Michelle Gearhart

Richard Nlemedim

Ben Hong

Priya Batheja

Elena Chekanovsky

Heather Persh

Amy Wilson

Lisa Schafer

Glenn Brame

Ben Halladay

Benjamin O. Looker

Betty Jean Swartz

Eric Warren

JoAnne Micale Foody

Rick Bartram

The Clinical Research and Development team at Esperion Therapeutics plays a critical role in designing, executing, and overseeing clinical trials for new LDL-C lowering therapies. This multidisciplinary team collaborates closely on clinical operations, scientific research, regulatory compliance, and data analysis to ensure the safety and efficacy of innovative treatments. Their efforts are essential in advancing therapeutic options that aim to reduce global cardiovascular disease.

Clinical Research and Development

Sales and Territory Management

Leadership Team

Clinical Research and Development

About

Team members

Other teams at Esperion Therapeutics

Sales and Territory Management

Leadership Team